PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50Â US$
0,00%
(0,00) 1 d
12 okt., 10:22:09 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för PTKFY …
Börsvärde
31,60Â bn
Genomsn. vol.
1,94Â tn
Volym
1,43Â tn
52v högst
16,36Â US$
52v lägst
7,63Â US$
Beta
0,09
Utestående aktier
234,07Â mn
Antal anställda
13Â tn
Börsvärde
31,60Â bn
Genomsn. vol.
1,94Â tn
Volym
1,43Â tn
52v högst
16,36Â US$
52v lägst
7,63Â US$
Beta
0,09
Utestående aktier
234,07Â mn
Antal anställda
13Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
ad-hoc-news.de
·
för 3 timmar sedan
Kalbe Farma reports 6,000 health packages while Kalbe Farma stock trades at EUR 0.03
ad-hoc-news.de
·
för 1 dag sedan
Buyback plans and results shaped Kalbe Farma stock review
Profil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Om PT Kalbe Farma Unsponsored Indonesia ADR